Korean Cosmetics: An Industry That Has Masked Weak Ingredients with Rapid Product Development
When you watch the cosmetics industry long enough, you start to sense who’s really making the money before the numbers even tell you. What sparkles on the retail shelf is the brand, but what really shapes the game behind the scenes is formulation, stabilization, and speed to launch. The real core of Korea’s cosmetics industry is not the illusion of branding but ODM development capability.
Sound like an overstatement? Then look at 2020–2024, when Amorepacific and COSRX stood side by side at the top of the domestic market. That tells you a traditional heavyweight and an emerging brand were winning at the same time. The face of the brand may change, but the ability to quickly develop products that sell and manufacture them repeatedly with stable quality does not change easily. It’s a good industry. But its weak links are also quite clear.
In the end, the money comes from development speed, not pretty packaging
The cosmetics value chain starts with raw materials/ingredients, then moves through containers/packaging, manufacturing/ODM, branding/marketing, distribution/sales, and support services. On the surface, brands take center stage, but the real quality of earnings depends on which stage holds the upper hand.
Korean cosmetics is not an industry built on absolute dominance in raw materials; it is much closer to a profit structure driven by manufacturing/ODM. That is why names like COSMAX, Kolmar Korea, and Cosmecca Korea keep coming up. Even when product planning changes and distribution channels get shaken up, the players that formulate, stabilize, and deliver on time are still indispensable.
| Stage | Description | Subsegments |
|---|---|---|
| Raw Materials/Ingredients | Cosmetic raw materials and core ingredients (including peptides, exosomes, and bio-based ingredients) | Base ingredients, functional ingredients, natural/organic ingredients, bio-based ingredients (peptides/exosomes), color cosmetic ingredients, fragrances/preservatives, etc. |
| Containers/Packaging | Cosmetic containers and packaging materials (including eco-friendly PCR and refill formats) | Glass containers, plastic containers, metal containers, pumps/caps, tubes, eco-friendly/PCR/refill containers, etc. |
| Manufacturing/ODM | Cosmetics ODM/OEM (global leaders Kolmar Korea and COSMAX) | Skincare ODM, color cosmetics ODM, haircare ODM, body care ODM, suncare ODM, sheet mask ODM, etc. |
| Branding/Marketing | Cosmetics brands (explosive growth in indie K-beauty) | Luxury brands, mass-market brands, K-indie brands, K-beauty brands, dermocosmetics, clean/vegan beauty, etc. |
| Distribution/Sales | Distribution (global e-commerce, live commerce, and expansion into the U.S., Japan, and Southeast Asia) | Department stores, H&B stores, duty-free shops, online/D2C, live commerce, global e-commerce, etc. |
| Support Services | Cosmetics industry support (certification, AI beauty tech, fulfillment) | Licensing/regulatory approval, quality testing/efficacy evaluation, R&D/labs, design/packaging, logistics/fulfillment, AI beauty tech/IT |
There’s no question they’re good at some things—but the weak spots are just as obvious
There’s always one point that gets muddled when people talk about localization. Korea is not good at everything. In certain processes and development capabilities, it ranks among the world’s best, but in basic materials and some core technologies, the gap is still wide. This industry has a pretty stark split between strengths and weaknesses.
Korea’s strengths are clearly in exosomes and regenerative materials, high-performance emulsions and formulations, transdermal delivery technology, stabilization and preservation technology, and comprehensive ODM development capabilities. APR, ExoCoBio, and Prostemics span exosomes and regenerative materials, while Amorepacific, LG H&H, and Cosmax have an unmistakable presence in formulation. Amorepacific, Cosmax, and Raphas are names that come up in absorption enhancement, while Kolmar Korea, Cosmecca Korea, and Daebong LS are strong in stabilization and preservation. What the industry truly values is not a flashy one-shot breakthrough, but stabilization that keeps sensitive ingredients viable all the way to the end. That’s much harder than it sounds.
On the flip side, weak technologies need to be viewed more coldly. Functional peptides, microbiome materials, eco-friendly and bio-based ingredients, UV protection technology, and virtual makeup/AR all fall into Gap 2. These are not just minor areas to patch up. If Korea wants to keep expanding the categories it already sells well, it ultimately cannot avoid its weaknesses in ingredient internalization and UV protection. UV protection technology in particular affects both skincare and makeup, so being weak here hurts more than people think. For now, Korea is making up for it with formulation and speed to launch—but for how long?
Table below: Domestic and global TRL (Technology Readiness Level 1–9) by technology, and key companies
| Technology | Korea | Global | Level | Key Companies | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingredients & Materials | ||||||||||||||||||||||||||||||||||
| Functional peptides | 7 | 9 | Catching up · Gap 2 | Advanced Beauty Science, Hyundai Bioland, Caregen | ||||||||||||||||||||||||||||||
| Peptides are short chains of a few amino acids—essentially fragments of 'mini proteins' that can be thought of as tiny instruction notes applied to the skin. Their mechanism is signal transmission: a specific peptide binds to receptors on the surface of skin cells and switches on signals such as 'make more collagen and elastin,' or slightly suppresses muscle-contraction signals to reduce expression lines—the so-called topical Botox concept. In other words, they mimic the way hormones or growth factors act as messengers in the body, but in cosmetic ingredient form. They are now core materials in high-end anti-aging lines, but the original peptide sequences and patents have largely been locked up by Swiss and U.S. companies, so Korean biotech firms such as Caregen are still catching up with proprietary sequences and fermentation/synthesis processes. The key thing to watch is how much 'clinically proven Korean peptides' can replace imported ingredients. | ||||||||||||||||||||||||||||||||||
| Microbiome materials | 6 | 8 | Catching up · Gap 2 | Amorepacific, Cosmax, GOBIOLAB | ||||||||||||||||||||||||||||||
| Microbiome cosmetics are designed to strengthen the skin barrier by restoring balance to the ecosystem of microorganisms that live on the skin. Just as probiotics support gut health, these products work by increasing beneficial microbes on the skin (probiotics), adding ingredients that feed them (prebiotics), or using fermented metabolites produced by those microbes (postbiotics) to suppress harmful bacterial growth and inflammation. The theoretical foundation is a skin-ecology view: when the skin microbiota collapses, the barrier weakens and trouble and sensitivity follow. So this is not an antibiotic-style kill-the-bacteria approach, but one focused on restoring balance. Korea, already strong in fermented cosmetics, is now in a fast catch-up phase, leveraging its kimchi and traditional fermentation know-how along with strain libraries. The key thing to watch is whether Korean players can secure patents on proprietary strains and build up clinical data. | ||||||||||||||||||||||||||||||||||
| Eco-friendly and bio-based ingredients | 6 | 8 | Catching up · Gap 2 | Hyundai Bioland, Daebong LS, Kolmar BNH | ||||||||||||||||||||||||||||||
| These are environmentally friendly ingredients made through plant or microbial fermentation, without animal testing or animal-derived materials. The core principle is precision fermentation: feeding sugar to yeast or microorganisms so they produce a desired substance—for example, replacing squalane once extracted from shark liver with sugarcane-fermented squalane. This approach protects endangered species, reduces carbon emissions, and also cuts quality variation. As EU environmental and supply-chain regulations (such as CSRD) tighten and vegan certification demands rise, eco-friendly ingredients are no longer optional—they are becoming a condition for export market access. The key thing to watch is whether fermentation-based ingredients can bring costs down to the level of natural extracts. | ||||||||||||||||||||||||||||||||||
| Exosomes and regenerative materials | 6 | 7 | Solid · Gap 1 | APR, ExoCoBio, Prostemics | ||||||||||||||||||||||||||||||
| Exosomes are extremely small 'delivery capsules,' roughly 100 nanometers in diameter, that cells release when exchanging information with one another. They contain regenerative signaling substances such as proteins and RNA, and the idea is that delivering these capsules to the skin can activate regeneration and soothing responses in surrounding cells. Instead of using stem cells directly, this approach selectively uses only the 'messages secreted' by stem cells, which offers advantages in safety and storage. The key technology is the process of isolating and purifying only exosomes from culture media at high purity. Korea is catching up quickly here, with companies such as ExoCoBio securing world-class patents in cosmetic exosomes. That said, pharmaceutical-grade exosomes face a much higher regulatory hurdle, so the first market to open up is post-procedure regenerative cosmetics and cosmeceuticals. | ||||||||||||||||||||||||||||||||||
| Formulation & R&D | ||||||||||||||||||||||||||||||||||
| High-performance emulsions and formulations | 8 | 9 | Solid · Gap 1 | Amorepacific, LG H&H, Cosmax | ||||||||||||||||||||||||||||||
| An emulsion is the technology of finely mixing two liquids that normally do not combine, such as water and oil, to create creams and lotions. The key principle lies in surfactants, or emulsifiers. These molecules have a water-loving head and an oil-loving tail at the same time, lowering the surface tension at the water-oil boundary so the two can coexist stably. The smaller and more evenly the oil droplets are broken up—nano-emulsions—the lighter the feel, the longer the hydration lasts, and the better the delivery of active ingredients. Korea is widely regarded as the world leader in formulation know-how that designs 'new sensory experiences,' from cushion compacts to dewy ampoules. The key thing to watch is how directly these formulation patents and sensory quality translate into ODM orders and global hits. | ||||||||||||||||||||||||||||||||||
| UV protection technology | 7 | 9 | Catching up · Gap 2 | Cosmax, Kolmar Korea, Dongindang | ||||||||||||||||||||||||||||||
| Sunscreen is a product that blocks ultraviolet rays (UVA and UVB), which cause skin aging, burns, and cancer. There are two protection mechanisms: inorganic filters (such as zinc oxide) scatter and reflect light like a mirror, while organic filters absorb UV energy and release it as heat. The technological core is formulating these UV-blocking ingredients so they apply lightly without white cast or stickiness—and on that front, Korea is world-class. But when it comes to entirely new UV filter materials themselves, Europe and Japan are ahead, and the U.S. FDA is also strict, leaving ingredient dependence as a lingering weakness. The key thing to watch is the expansion of exports of lightweight Korean-style sunscreens to the U.S. and Southeast Asia, along with localization of UV filter ingredients. | ||||||||||||||||||||||||||||||||||
| Transdermal delivery technology (absorption enhancement) | 7 | 8 | Solid · Gap 1 | Amorepacific, Cosmax, Raphas | ||||||||||||||||||||||||||||||
| This is the technology of effectively delivering active ingredients to the target depth inside the skin. The outermost stratum corneum is a defensive wall like a brick barrier, so even good ingredients tend to sit on the surface. The key is how to get through that barrier. One method is to wrap the ingredient in tiny oil-membrane capsules that resemble skin lipids (liposomes), allowing it to seep naturally through the barrier. Another is to use microneedles—tiny needles finer than a strand of hair—to create microchannels in the stratum corneum and push ingredients in. Recently, ampoules that aid penetration with micro-spicules, such as VT Reedle Shot, have become major hits both in Korea and overseas, turning transdermal delivery into a mainstream marketing keyword. The key thing to watch is whether mass-production technology for microneedle patches, held by companies such as Raphas, expands beyond cosmetics into drug and vaccine delivery. | ||||||||||||||||||||||||||||||||||
| Stabilization and preservation technology | 7 | 8 | Solid · Gap 1 | Kolmar Korea, Cosmecca Korea, Daebong LS | ||||||||||||||||||||||||||||||
| This is the technology that protects ingredients such as vitamin C and retinol—highly effective but easily degraded by air, light, and heat—so they retain their efficacy all the way to the end. There are two main approaches. One is to coat unstable ingredients or lock them inside capsules to block contact with oxygen and light. The other is to slow degradation through antioxidant formulations, pH control, and container design. At the same time, preservative-free or low-irritation formulations are becoming more important, minimizing preservatives while still preventing microbial contamination to reduce skin irritation and allergies. As high-concentration ampoules and boosters proliferate, the formulation challenge has risen: 'increase concentration while preserving stability.' The key thing to watch is how stabilization know-how underpins efficacy claims and product credibility. | ||||||||||||||||||||||||||||||||||
| ODM/OEM Manufacturing | ||||||||||||||||||||||||||||||||||
| Comprehensive ODM development capabilities | 9 | 9 | Solid · Gap 0 | Cosmax, Kolmar Korea, Cosmecca Korea | ||||||||||||||||||||||||||||||
| ODM is a business model in which a manufacturer takes a brand’s order and handles everything from formulation development to testing, production, and quality control. The brand only needs to provide the concept and idea, and it can receive a finished product—meaning it can launch a cosmetics business without owning a factory. Cosmax and Kolmar Korea rank No. 1 and No. 2 globally in ODM, and countless indie brands in the U.S. and Europe, along with major global brands, manufacture products in Korean ODM factories. In other words, the real engine behind the surge in exports by K-beauty indie brands is this ODM infrastructure. The essence of competitiveness is a formulation library that can productize trends quickly, along with mass-production capability. The key thing to watch is that as global brand orders increase, Korea further cements its position as the 'world’s cosmetics R&D and manufacturing factory.' | ||||||||||||||||||||||||||||||||||
| Smart production and quality control | 7 | 8 | Solid · Gap 1 | Cosmax, Kolmar Korea, LG H&H | ||||||||||||||||||||||||||||||
| This is the technology of introducing sensors, data, and automation into factories to keep quality consistent and reduce defects. In cosmetics, even slight differences in color, scent, viscosity, or pH can trigger complaints, so manufacturers need process control systems—smart factories—that measure these values in real time during production and immediately catch anything that falls outside the standard. The principle is to accumulate and analyze manufacturing data to predict and control the causes of degradation, contamination, and variation in advance, standardizing processes numerically instead of relying on human intuition. As indie brand orders rise and small-batch, multi-product manufacturing becomes routine, flexible automation that can preserve quality even with frequent line changes has emerged as a key challenge. The key thing to watch is that the level of automation directly determines lead-time and cost competitiveness. | ||||||||||||||||||||||||||||||||||
| Global production bases and certifications | 8 | 9 | Solid · Gap 1 | Cosmax, Kolmar Korea, Cosmecca Korea | ||||||||||||||||||||||||||||||
| This refers to the ability of major ODM companies to operate factories directly in China, the U.S., and Southeast Asia and produce in line with local regulations and certifications. Since each country has different cosmetic approval standards and ingredient rules—such as U.S. MoCRA, China NMPA, and EU CPNP—having local factories and certifications allows companies to overcome tariff, logistics, and review barriers and enter markets quickly. The operating model is not a single 'export-oriented factory,' but a multi-base strategy that localizes formulation, production, and certification by market. As the U.S. emerges as the largest export market, Cosmax and Kolmar Korea are expanding local capacity. The key thing to watch is that local production and certification capability directly translates into the ability to win global brand orders. | ||||||||||||||||||||||||||||||||||
| Small-batch and customized production (multi-product) | 7 | 7 | Solid · Gap 0 | Cosmecca Korea, Kolmar Korea, C&C International | ||||||||||||||||||||||||||||||
| This is a production model that moves away from churning out one product in massive volume and instead makes smaller quantities in greater variety and at higher speed. Online and indie brands launch small runs frequently to match social media trends, so the key is maintaining efficiency and quality even while switching multiple products through a single line on short cycles. The principle is flexible line design that reduces equipment changeover time, along with process standardization that lowers MOQ (minimum order quantity). Companies specialized in multi-product manufacturing, such as color cosmetics ODM player C&C International, are benefiting from the sharp rise in indie brand exports. The key thing to watch is that the ability to handle small-batch, high-turnover production helps lock in new brands as long-term customers. | ||||||||||||||||||||||||||||||||||
| Derma & Functional | ||||||||||||||||||||||||||||||||||
| Wrinkle improvement (anti-aging) | 8 | 9 | Solid · Gap 1 | Amorepacific, LG H&H, Dongkook Pharmaceutical | ||||||||||||||||||||||||||||||
| These are functional cosmetics that reduce wrinkles by stimulating collagen and elastin production in the dermis. A representative ingredient, retinol (a vitamin A derivative), works by converting into retinoic acid inside cells, switching on collagen-production genes and suppressing the breakdown enzymes that increase with aging. But because retinol is powerful, it also tends to cause irritation and redness, making stabilization and controlled-release formulation technology—the ability to reduce irritation while preserving efficacy—the core battleground. Under Korea’s MFDS-certified 'functional cosmetics' system, the country has built strengths across a range of formulations using retinol, peptides, bakuchiol, and more. The key thing to watch is the trend toward clinically proving efficacy and expanding the premium market at the boundary between pharmaceuticals and cosmetics. | ||||||||||||||||||||||||||||||||||
| Brightening and pigmentation improvement | 8 | 8 | Solid · Gap 0 | Amorepacific, LG H&H, Cosmax | ||||||||||||||||||||||||||||||
| These are functional cosmetics that brighten skin tone by preventing excessive production of melanin, the pigment behind melasma, dark spots, and dullness. The mechanism is either to slow the action of tyrosinase, the key enzyme that synthesizes melanin, or to block the process by which already-formed pigment rises to the skin surface. Representative ingredients include niacinamide, vitamin C, and arbutin, each working through slightly different pathways such as enzyme inhibition, blocking pigment transfer, or antioxidant action. Demand is especially strong in Asian markets that favor bright, even skin tone, and Korea has built deep strengths in brightening formulations and clinical data. The key thing to watch is the expansion of the market through 'tonal care' that combines brightening with UV protection and antioxidants. | ||||||||||||||||||||||||||||||||||
| Skin barrier and regeneration | 8 | 8 | Solid · Gap 0 | LG H&H, Manyo Factory, Dr.Jart+ (Estée Lauder) | ||||||||||||||||||||||||||||||
| This is the technology of restoring dryness, tightness, and sensitivity caused by a weakened outer skin barrier, the stratum corneum. The stratum corneum is often compared to a wall built of bricks (skin cells) and cement (lipids). If the lipids acting as that cement—especially ceramides—are lacking, moisture leaks out and external irritants get in easily. So the mechanism is to refill the wall by replenishing ceramides, cholesterol, and fatty acids in ratios similar to the skin’s own, while calming inflammation with soothing ingredients such as cica (Centella asiatica extract). As the population with sensitive skin and skin troubles grows, derma-cosmetics are expanding rapidly into pharmacy and hospital channels as well. The key thing to watch is that clinically grounded trust translates into brand loyalty. | ||||||||||||||||||||||||||||||||||
| Specialized care for acne, scalp, etc. | 7 | 8 | Solid · Gap 1 | Manyo Factory, Dr.G, Amorepacific | ||||||||||||||||||||||||||||||
These are functional products that precisely target specific concerns such as acne, pores, scalp issues, and hair-loss relief. What sets them apart is that they intervene directly in the cause rather than stopping at general hydration. For example, acne care combines ingredients that dissolve the dead skin cells clogging pores (such as salicylic acid) with ingredients that reduce acne-causing bacteria and sebum secretion, breaking the chain of causes behind the problemTechnology Roadmap
The Face of No. 1 Has Changed, but the Global No. 1 Hasn’tThe shift in market leaders becomes even clearer when you look at each era. Globally, the No. 1 player has been L'Oréal throughout 1990s~2008, 2009~2016, 2017~2019, 2020~2024, and 2025~present. That’s not a coincidence. Cosmetics may look like a trend-driven industry, but in reality, the companies that win are the ones that have spent years compounding technology, brand equity, and distribution.
In Korea, the pattern is a bit different. The domestic leader was Amorepacific in 1990s~2008 and 2009~2016, LG H&H in 2017~2019, and Amorepacific and COSRX together in 2020~2024 and 2025~present. What this shift tells us is that Korea’s market leadership has moved from absolute dominance to a multi-winner structure. Put positively, the ecosystem has become much deeper. Put less kindly, it also means brand-side barriers to entry are lower than they used to be. The emergence of a case like COSRX shows that Korea is no longer a stage reserved only for big corporate brands. And yet the global No. 1 is still L'Oréal. That gap is the key point. Korea can create hit products quickly, but it still hasn’t fully built the kind of structure that can dominate technology, brand, and platform all at once over the long haul on a global scale. Going forward, weak spots in poorly made products may stand out more than well-made products themselvesThe key things to watch from here are clear: whether the comprehensive ODM development capabilities represented by Cosmax, Kolmar Korea, and Cosmecca Korea continue to serve as the industry’s engine, and how much brand players like Amorepacific, LG H&H, and COSRX can differentiate themselves on top of that. More important than short-term earnings momentum is the depth of capability in shoring up weaknesses in raw-material technologies and in sun protection and eco-friendly ingredients. The risks are also clear. If functional peptides, microbiome materials, eco-friendly and bio-based ingredients, and virtual makeup/AR continue to lag, Korean cosmetics may remain a country that makes products well, but it will struggle to become a country that controls the underlying source technologies. That gap only widens over time. Frankly, the strengths of Korean cosmetics today are already quite solid. But if the weak links are ignored, it may remain not a great industry, but simply an industry that sells well. ※ This article is an analysis compiled based on public data and industry materials, and some figures and assessments are estimates. It is not intended as a direct basis for investment decisions. Written: June 2026. E. Alexandro | ||||||||||||||||||||||||||||||||||
댓글
댓글 쓰기